NITINOL MEDICAL TECHNOLOGIES INC
SC 13G/A, 1998-02-10
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: CAROLINA FINCORP INC, 10QSB, 1998-02-10
Next: NITINOL MEDICAL TECHNOLOGIES INC, SC 13G/A, 1998-02-10



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                _____________                              

                                 SCHEDULE 13G
                                (Rule 13d-102)
                                 
     INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)
        and (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)

                              (Amendment No.1)/1/

                      NITINOL MEDICAL TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
                               (Name of Issuer)

                    COMMON STOCK, PAR VALUE $.001 PER SHARE
- --------------------------------------------------------------------------------
                        (Title of Class of Securities)

                                   65476T104
                                --------------
                                (CUSIP Number)

/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

                                  Page 1 of 6
<PAGE>

CUSIP No. 65476T104             13G                        Page 2  of 6  Pages


1  NAME OF REPORTING PERSON
   S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
        
   Fletcher Spaght, Inc.
   ID# _________________
 
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*            (a) [_]

                                                                (b) [_]

3  SEC USE ONLY


4  CITIZENSHIP OR PLACE OF ORGANIZATION
   State of Delaware
        
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH


        5  SOLE VOTING POWER
                  
           615,842 shares (includes 111,818 shares which Fletcher Spaght, Inc. 
           has the right to acquire within 60 days after December 31, 1997)     

        6  SHARED VOTING POWER

           0 shares       

        7  SOLE DISPOSITIVE POWER

           615,842 shares (includes 111,818 shares which Fletcher Spaght, Inc. 
           has the right to acquire within 60 days after December 31, 1997)     

        8  SHARED DISPOSITIVE POWER
                  
           0 shares

9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        
   615,842 shares (includes 111,818 shares which Fletcher Spaght, Inc. 
   has the right to acquire within 60 days after December 31, 1997)        

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
        
   Not Applicable                

11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        
   6.2%
   
12 TYPE OF REPORTING PERSON*
        
   CO

                     *SEE INSTRUCTION BEFORE FILLING OUT!

<PAGE>
 
CUSIP NO. 65476T104
- -------------------

Item 1(a)       Name of Issuer:
- ---------       --------------

                Nitinol Medical Technologies, Inc.

Item 1(b)       Address of Issuer's Principal Executive Office:
- ---------       ----------------------------------------------

                27 Wormwood Street
                Boston, MA 02210

Item 2(a)       Name of Person Filing:
- ---------       ---------------------

                Fletcher Spaght, Inc.

Item 2(b)       Address of Principal Business Office or, if none, Residence:
- ---------       -----------------------------------------------------------

                222 Berkeley Street
                Boston, MA 02116-3761

Item 2(c)       Citizenship:
- ---------       -----------

                State of Delaware

Item 2(d)       Title of Class of Securities
- ---------       ----------------------------

                Common Stock, $.001 par value per share

Item 2(e)       CUSIP Number:
- ---------       ------------ 

                65476T104

Item 3          Description of Person Filing:         
- ------          ----------------------------

                Not applicable.

Item 4          Ownership:
- ------          ---------

                (a)  Amount Beneficially Owned:  
                     -------------------------

                     615,842 shares (includes 111,818 shares which Fletcher
                     Spaght, Inc. has the right to acquire within 60 days after
                     December 31, 1997)

                                  Page 3 of 6
<PAGE>
 
CUSIP No. 65476T104
- -------------------

               (b)  Percent of Class:
                    ----------------

                    6.2%

               (c)  Number of shares as to which person has:
                    ---------------------------------------

                    (i)    sole power to vote or to direct the vote:
     
                           615,842 shares (includes 111,818 shares which
                           Fletcher Spaght, Inc. has the right to acquire within
                           60 days after December 31, 1997)                   

                    (ii)   shared power to vote or to direct the vote:

                           0 shares

                    (iii)  sole power to dispose or to direct the disposition 
                           of:

                           615,842 shares (includes 111,818 shares which
                           Fletcher Spaght, Inc. has the right to acquire within
                           60 days after December 31, 1997)               

                    (iv)   shared power to dispose or to direct the disposition 
                           of:

                           0 shares

Item 5         Ownership of Five Percent or Less of a Class:
- ------         --------------------------------------------

               Not applicable.

Item 6         Ownership of More than Five Percent on Behalf of Another Person:
               --------------------------------------------------------------- 

               Not applicable.

Item 7         Identification and Classification of the Subsidiary Which 
- ------         ---------------------------------------------------------
               Acquired the Security Being Reported on by the Parent Holding
               -------------------------------------------------------------
               Company:
               -------

               Not applicable.


                                  Page 4 of 6
<PAGE>
 
CUSIP No. 65476T104
- -------------------

Item 8      Identification and Classification of Members of the Group:
- ------      ---------------------------------------------------------
         
            Not applicable.
         
Item 9      Notice of Dissolution of Group:
- ------      ------------------------------
         
            Not applicable.
         
Item 10     Certification:
- -------     -------------
         
            Not applicable.

                                  Page 5 of 6
<PAGE>
 
CUSIP No. 65476T104
- -------------------

                                   SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and 
correct.

DATED:  February 6, 1998                    FLETCHER SPAGHT, INC. 

                                            By: /s/ R. John Fletcher
                                               ------------------------------
                                               Name: R. John Fletcher
                                               Title: Chief Executive Officer
                                                                 
                              Page 6 of 6                                      


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission